Lastly, LLL-12B was shown by Pan et al. to inhibit triple-negative BrCa (TNBC) via a mammary fat pad tumor model, supporting the notion of targeting STAT3 for TNBC [205]. The gene discussed is STAT3; the disease is neoplasm.